| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 15.627 | 43.870 | 51.936 | 68.758 | 88.387 | 95.469 |
| Total Income - EUR | - | - | - | - | 15.627 | 43.988 | 51.938 | 68.767 | 88.394 | 97.416 |
| Total Expenses - EUR | - | - | - | - | 9.119 | 31.015 | 38.209 | 33.291 | 39.706 | 42.420 |
| Gross Profit/Loss - EUR | - | - | - | - | 6.508 | 12.972 | 13.729 | 35.476 | 48.688 | 54.996 |
| Net Profit/Loss - EUR | - | - | - | - | 6.352 | 12.543 | 13.276 | 34.891 | 47.821 | 52.310 |
| Employees | - | - | - | - | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Ivamedicine S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 3.682 | 3.968 | 4.535 | 20.088 |
| Current Assets | - | - | - | - | 10.231 | 18.682 | 15.241 | 36.115 | 51.658 | 50.055 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 3.909 | 3.916 | 4.393 | 6.232 | 15.633 | 1.347 |
| Cash | - | - | - | - | 6.322 | 14.766 | 10.848 | 29.883 | 36.025 | 20.563 |
| Shareholders Funds | - | - | - | - | 6.394 | 12.615 | 13.346 | 35.045 | 47.862 | 52.351 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 3.836 | 6.067 | 5.577 | 5.039 | 8.331 | 3.593 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 14.199 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Ivamedicine S.r.l.